SCHEMBL30906345

SCHEMBL30906345

CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 13/20 0.65
▸ BACE2 Q9Y5Z0 6/20 0.65
▸ GLP1R P43220 1/20 0.59
▸ GCGR P47871 1/20 0.59
▸ GIPR P48546 1/20 0.59
▸ VIPR1 P32241 1/20 0.55
▸ CTSD P07339 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31514339 0.95 BACE1 (0.70) BACE1BACE2CTSD
SCHEMBL31688316 0.92 GLP1R (0.56) BACE1BACE2GLP1RGCGRGIPR
SCHEMBL31182625 0.91 BACE1 (0.57) BACE1BACE2GLP1RGCGRGIPR
SCHEMBL29609357 0.91 TFPI (0.64) BACE1BACE2GLP1RGCGRGIPR
SCHEMBL31683306 0.90 GLP1R (0.57) BACE1BACE2GLP1RGCGRGIPR
SCHEMBL30880910 0.90 BACE1 (0.55) BACE1BACE2GLP1RGCGRGIPR
SCHEMBL30428639 0.90 BACE1 (0.56) BACE1BACE2GLP1RGCGRGIPR
SCHEMBL31182595 0.89 GLP1R (0.68) GLP1RGCGRGIPRVIPR1
SCHEMBL30903279 0.89 BACE1 (0.62) BACE1GLP1RGCGRGIPRVIPR1
SCHEMBL30607352 0.89 GLP1R (0.57) BACE1BACE2GLP1RGCGRGIPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598964-A2 ANTI-IGE ANTIBODIES Abwiz Bio, Inc. (US) 2025-08-13 — — EP disclosed
US-20240182599-A1 ANTI-IGE ANTIBODIES ABWIZ BIO, INC. 2024-06-06 — — US disclosed
WO-2024076785-A2 ANTI-IGE ANTIBODIES ABWIZ BIO, INC. (US) 2024-04-11 — — WO disclosed
Send feedback